EPISODE · Jan 9, 2022 · 12 MIN
TRIIM Growth Hormone Safety Metrics Dr Greg Fahy Episode 3
from Modern Healthspan · host Modern Healthspan
In this video Dr. Fahy discusses growth hormone and it benefits in aging. He also covers the safety checks that they performed after the participants started with the protocol. In particular they saw reduced markers of cancer and cancer risk Dr. Greg Fahy is a world renowned cryobiologist and is also the chief science officer, and co-founder, of Intervene Immune, a company which pioneers treatments for thymus regeneration and age-related immune system decline. Dr. Fahy Designed and led the pilot TRIIM trial which first time showing both thymus rejuvenation and reversal of human epigenetic age. He is now running the follow up phase II trial TRIIM-X with the aim of confirming and extending the results. If you would like to support our channel, we’d love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan
Embed this episode
NOW PLAYING
TRIIM Growth Hormone Safety Metrics Dr Greg Fahy Episode 3
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.